Activity Provided By:

CancerNet, LLC and Amedco, LLC.

Current and Emerging Treatment Options for Renal Cell Carcinoma

Overview / Abstract:	Target Audience This activity is designed to meet the educational needs of urologists, medical oncologists, nephrologists, radiation oncologists, surgeons, physician assistants, nurse practitioners, nurses, and healthcare professionals involved in the treatment of renal cell carcinoma patients. Program Overview This activity will cover topics on the diagnosis, treatment, and management of patients with renal cell carcinoma. Learning Objectives Upon completion of this activity, participants should be better able to: Evaluate immunotherapy options with immune checkpoint inhibitors (ICI) and targeted therapy combinations for RCC Assess sequential treatment strategies and combination therapies for RCC with multitargeted kinase inhibitors Interpret the adverse events in patients treated with ICI and targeted therapy combinations in RCC
Expiration	Aug 10, 2021
Discipline(s)	Physician CME
Format	Online
Credits / Hours	1.25
Accreditation	ACCME, ACPE, ANCC
Presenters / Authors / Faculty	Toni Choueiri, MD Eric Jonasch, MD
Sponsors / Supporters / Grant Providers	Exelixis
Keywords / Search Terms	Relias LLC Relias, Free CME, Renal Cell Carcinoma Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map